The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma

Yihong Zhou,Liang Tong,Xi Chu,Fei Deng,Jin Tang,Yuxin Tang,Yingbo Dai

The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma

2017

Yihong Zhou
Liang Tong
Xi Chu
Fei Deng
Jin Tang
Yuxin Tang
Yingbo Dai

Background/Aims: The adenosine A1 receptor (A1R) has been reported to be involved in the pathogenesis of various cancers, and the effects of A1R on different canc

Keywords:

Cancer research
Diabetes mellitus
Biochemistry
Antagonist
Adenosine A3 receptor
MAPK/ERK pathway
Biology
Endocrinology
Renal cell carcinoma
Tumor progression
Pathogenesis
Internal medicine
Adenosine A1 receptor
Cell growth
Cell cycle
MTT assay
Cell migration
Apoptosis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations